• Homepage
  • Baculoviral IAP Repeat-Containing 7 ELISA Kits

Baculoviral IAP Repeat-Containing 7 (BIRC7) ELISA Kits

The protein encoded by BIRC7 is a member of the family of inhibitor of apoptosis proteins (IAP) and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. Additionally we are shipping Baculoviral IAP Repeat-Containing 7 Antibodies (170) and Baculoviral IAP Repeat-Containing 7 Proteins (17) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
BIRC7 79444 Q96CA5
BIRC7 296468  
BIRC7 329581 A2AWP0
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Baculoviral IAP Repeat-Containing 7 ELISA Kits at antibodies-online.com

Showing 8 out of 11 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 20pg/mL 0.78-50 ng/mL Human Livin PicoKine ELISA Kit standard curve 96 Tests 4 to 6 Days
$333.00
Details
Human 0.059 ng/mL 0.15 ng/mL - 10 ng/mL 96 Tests 13 to 16 Days
$736.84
Details
Human 0.01 ng/mL n/a   96 Tests 11 to 16 Days
$673.75
Details
Mouse
  96 Tests 31 to 41 Days
$734.80
Details
Mouse
  96 Tests 26 to 36 Days
$899.80
Details
Rat
  96 Tests 31 to 41 Days
$734.80
Details
Rat
  96 Tests 26 to 36 Days
$899.80
Details
Human < 0.059 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests 11 to 18 Days
$902.56
Details

More ELISA Kits for Baculoviral IAP Repeat-Containing 7 Interaction Partners

Human Baculoviral IAP Repeat-Containing 7 (BIRC7) interaction partners

  1. Livin induced a colon cancer phenotype, including proliferation and migration, by regulating H2A.X(Y39ph) (histone family 2A variant (H2AX) phosphorylated on the 39th serine site).

  2. BIRC7 upregulation might serve as a valuable biomarker of increased recurrence risk.

  3. The overexpression of PTEN concomitant with Livin gene silencing was confirmed as a feasible and effective in vitro and in vivo gene modulation method, which may represent a potential therapeutic strategy for the treatment of Gastric Cancer.

  4. Livin overexpression not only significantly inhibited RCC cell apoptosis and increased cell viability, but completely reversed the si-CCAT1-mediated repression of cell viability

  5. our results revealed that Livin induced EMT through the activation of the p38/GSK3beta pathway, which in turn promoted the progression and metastasis of breast cancer, especially for triple-negative breast cancer (TNBC)

  6. our results suggest that siRNA-mediated Livin knockdown enhanced the chemosensitivity of the three head and neck squamous cell carcinoma cell lines to cisplatin, 5-FU and docetaxel.

  7. Livin is specifically over-expressed in adrenocortical carcinoma.

  8. Further experiments confirmed the induction of cell apoptosis and suppression of cell proliferation by anti-MM scFv-tP in LiBr cells, along with efficient silence of Livin gene both in vitro and in vivo. Altogether, our findings provide a feasible approach to transport Livin small interfering RNA to malignant melanoma cells which would be a new therapeutic strategy for combating malignant melanoma

  9. MicroRNA-214 inhibits the osteogenic differentiation of human osteoblasts through the direct regulation of BIRC7.

  10. the results of the present study suggested that Livin may enhance tumorigenesis by modulating the mitogenactivated/Akt signaling pathways in human HSCC.

  11. Positive BIRC7 expression and negative KLF4 expression are associated with the progression of PDAC and poor prognosis in patients with PDAC.

  12. High expression of BIRC7 is associated with drug resistance in Renal cell carcinoma.

  13. Data show that cylindromatosis (CYLD) overexpression and livin knockdown might improve gemcitabine chemosensitivity by decreasing autophagy and increasing apoptosis in bladder cancer (BCa) cells.

  14. The apoptosisinducing effects of livin and surivin knockdown were investigated using a Hoechst staining kit.

  15. Expression of livin, survivin and caspase-3 are closely related to the occurrence and development of prostatic cancer.

  16. Our results suggested the important role of Livin and its partner molecule in the process of VSV treatment

  17. Data showed that Livin knock-down suppressed cell proliferation and inhibited cell invasion, accompanied by downregulation of VEGF and MMP-2/-9. Its silencing resulted in the prevention of xenograft tumor formation.

  18. These findings suggest that livin may be used as a novel target for tumor gene therapy.

  19. Upregulation of Livin expression and downregulation of caspase activity are observed under cycling and chronic hypoxia in glioblastoma cells and xenografts.

  20. Livin expression was higher in condyloma acuminatum than in normal cells and was correlated with survivin and Ki-67.

Mouse (Murine) Baculoviral IAP Repeat-Containing 7 (BIRC7) interaction partners

  1. The overexpression of PTEN concomitant with Livin gene silencing was confirmed as a feasible and effective in vitro and in vivo gene modulation method, which may represent a potential therapeutic strategy for the treatment of Gastric Cancer.

  2. Data showed that Livin knock-down suppressed cell proliferation and inhibited cell invasion, accompanied by downregulation of VEGF and MMP-2/-9. Its silencing resulted in the prevention of xenograft tumor formation.

  3. Birc7 is a late fiber gene of the mouse lens. Its expression in cells bordering the OFZ is consistent with a role in organelle degradation, a process in which the ubiquitin proteasome pathway has been implicated previously.

  4. ML-IAP is dispensable for both normal mouse development and ocular homoeostasis.

Baculoviral IAP Repeat-Containing 7 (BIRC7) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the family of inhibitor of apoptosis proteins (IAP) and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. The BIR domain is essential for inhibitory activity and interacts with caspases, while the RING finger domain sometimes enhances antiapoptotic activity but does not inhibit apoptosis alone. Two transcript variants encoding different isoforms have been found for this gene. The two isoforms have different antiapoptotic properties, with isoform alpha protecting cells from apoptosis induced by staurosporine and isoform b protecting cells from apoptosis induced by etoposide.

Gene names and symbols associated with BIRC7

  • baculoviral IAP repeat containing 7 (BIRC7) antibody
  • baculoviral IAP repeat containing 7 (birc7) antibody
  • baculoviral IAP repeat-containing 7 (Birc7) antibody
  • baculoviral IAP repeat-containing 7 (livin) (Birc7) antibody
  • baculoviral IAP repeat containing 7 S homeolog (birc7.S) antibody
  • birc7 antibody
  • bird7a antibody
  • E130019N06 antibody
  • EIAP/XLX antibody
  • kiap antibody
  • Livin antibody
  • ml-iap antibody
  • mliap antibody
  • RGD1562883 antibody
  • rnf50 antibody
  • xEIAP antibody
  • xEIAP/XLX antibody
  • xlx antibody
  • zgc:165605 antibody

Protein level used designations for BIRC7

RING finger protein 50 , baculoviral IAP repeat-containing protein 7 , kidney inhibitor of apoptosis protein , livin inhibitor of apoptosis , melanoma inhibitor of apoptosis protein , baculoviral IAP repeat-containing 7 , E3 ubiquitin-protein ligase EIAP , Embryonic/Egg IAP , baculoviral IAP repeat-containing 7 (livin) , E3 ubiquitin-protein ligase EIAP-A , IAP-like protein , XIAP homolog XLX , baculoviral IAP repeat-containing 7 a , baculoviral IAP repeat-containing protein 7 a , baculoviral IAP repeat-containing protein 7-A , embryonic/Egg IAP , inhibitor of apoptosis-like protein

GENE ID SPECIES
79444 Homo sapiens
697671 Macaca mulatta
100127811 Xenopus (Silurana) tropicalis
296468 Rattus norvegicus
485969 Canis lupus familiaris
514508 Bos taurus
100073331 Danio rerio
419239 Gallus gallus
329581 Mus musculus
398387 Xenopus laevis
Selected quality suppliers for Baculoviral IAP Repeat-Containing 7 (BIRC7) ELISA Kits
Did you look for something else?